Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Center for International Blood and Marrow Transplant Research
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Roswell Park Cancer Institute
City of Hope Medical Center
City of Hope Medical Center
Case Comprehensive Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Thomas Jefferson University
Indiana University
Asan Medical Center
M.D. Anderson Cancer Center
University of Birmingham
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
H. Lee Moffitt Cancer Center and Research Institute
Roswell Park Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Masonic Cancer Center, University of Minnesota
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
Barbara Ann Karmanos Cancer Institute
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
Hospital Israelita Albert Einstein
University of Rochester
Barbara Ann Karmanos Cancer Institute
Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
SWOG Cancer Research Network
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
City of Hope Medical Center